Siemens Healthcare (Booth 922) is showcasing syngo Lung CAD, syngo CXR CAD and syngo MammoCAD for RSNA-goers. Siemens is focusing on the integration of CAD into advanced 3D applications, as well as the use of CAD in the PACS workflow.
syngo Lung CAD automatically detects solid pulmonary nodules in thoracic CT studies. The CAD tool plays a role as a second reader to aid in the interpretation of complex chest CT data sets. syngo Lung CAD is available on the syngo MultiModality Workplace for use with syngo CT Oncology. Additionally, to enable the CAD results to be displayed on PACS workstations, syngo Lung CAD is integrated in the reading workflow of syngo Imaging and syngo Imaging XS.
syngo CXR CAD, which is not yet FDA-approved for sale in the U.S., is a second reader product for the detection of lung nodules in digital chest x-ray studies. syngo CXR CAD processes images of the posterior-anterior view and is optimized for the detection of lung nodules from 8mm to 30mm in size. syngo CXR CAD is validated for use with images from the Siemens Axiom Aristos digital x-ray system, and the results can be displayed on PACS workstations.
syngo MammoCAD, which is not yet FDA-approved for sale in the U.S., is a CAD solution for full-field digital mammography and generates CAD marks to highlight suspicious areas, such as masses and microcalcifications. With syngo MammoCAD, up to 40 percent of normal cases show no false positive CAD marks, saving the radiologist interpretation time during the second read phase, Siemens says. In combination with the syngo MammoReport workstation, additional features include: breast density in MammoBrowser; additional CAD information provides the number of calcifications in a cluster; and corridor of interest, an identification of marked lesion in second view using CAD findings.